Skip to main content
Log in

Colonic Absorption of Insulin-like Growth Factor I in Vitro

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Colonic absorption of recombinant human insulin-like growth factor I (rhIGF-I) was measured in vitro using both rat and minipig colon. The permeability coefficients were 8.03 ± 1.03 and 4.75 ± 0.43 × 10−8 cm sec−1 in the rat and minipig, respectively. The steady-state flux in rat colon was linearly related to the donor concentration over the range 1 to 10 mg/mL. rhIGF-I was metabolically stable in contact with both mucosal and serosal surfaces of washed colon for 5 hr. The amount of IGF-I permeating through the tissue was quantitated by radioimmunoassay and the identity and integrity of the permeating species were confirmed by reverse-phase HPLC, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, and Western blotting. In all cases the permeant was identical to authentic rhIGF-I. The integrity of the colonic tissue in vitro was demonstrated by the maintenance of electrophysiological parameters, a secretory response to serosal theophylline, and the ability of sodium azide, a metabolic inhibitor, to abolish the barrier properties and cause a large increase in flux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. E. Rinderknecht and R. E. Humbel. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem. 253:2769–2776 (1978).

    Google Scholar 

  2. S. Gammeltoft. Insulin-like growth factors and insulin: Gene expression, receptors, and biological actions. In J. Martinez (ed.), Peptide Hormones as Prohormones: Processing, Biological Activity, Pharmacology, Halsted Press, New York, 1989.

    Google Scholar 

  3. V. R. Sara and K. Hall. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:591–614 (1990).

    Google Scholar 

  4. S. Hardouin, P. Hossenlopp, B. Segouia, D. Seurin, G. Portolan, C. Lassame, and M. Binoux. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. I. Circulating forms in man. Eur. J. Biochem. 170:121–132 (1987).

    Google Scholar 

  5. P. E. Walton, R. Gopinath, B. D. Burleigh, and T. D. Etherton. Administration of recombinant human insulin-like growth factor I to pigs: Determination of circulating half-lives and chromatographic profiles. Horm. Res. 31:138–142 (1989).

    Google Scholar 

  6. S. C. Hodgkinson, S. R. Davis, B. D. Burleigh, H. V. Henderson, and P. D. Gluckman. Metabolic clearance rate of insulin-like growth factor-I in fed and starved sheep. J. Endocr. 115:233–240 (1987).

    Google Scholar 

  7. D. S. Schalch, N. J. Turman, V. Marcsisin, and H. P. Guler. Short-term metabolic effects of recombinant human insulin-like growth factor I (rhIGF-I) in type II diabetes mellitus. 2nd International IGF Symposium on Insulin-Like Growth Factors/Somatomedins, 1991.

  8. A. Giacca, R. Gupta, S. Efendic, K. Hall, A. Skottner, L. Lickley, and M. Vranic. Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatized dogs. Diabetes 39:340–347 (1990).

    Google Scholar 

  9. F. M. Tomas, S. E. Knowles, P. C. Owens, L. C. Read, C. S. Chandler, S. E. Gargosky, and F. J. Ballard. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF-I) and des(1–3)IGF-I. Biochem. J. 276:547–554 (1992).

    Google Scholar 

  10. E. M. Spencer, C. C. Liu, E. C. C. Si, and G. A. Howard, In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 12:21–26 (1991).

    Google Scholar 

  11. S. A. W. Gibson, C. McFarlan, S. Hay, and G. T. MacFarlane. Significance of microflora in proteolysis in the colon. Appl. Env. Microbiol. 55:679–683 (1989).

    Google Scholar 

  12. M. Proano, M. Camilleri, S. F. Phillips, M. L. Brown, and G. M. Thomforde. Transit of solids through the human colon: Regional quantification in the unprepared bowel. Am. J. Physiol. 258:G856–G862 (1990).

    Google Scholar 

  13. B. Krevsky, L. S. Malmud, F. D'Ercole, A. H. Maurer, and R. S. Fisher. Colonic transit scintigraphy. A physiological approach to the quantitative measurement of colonic transit in humans. Gastroenterology 91:1102–1112 (1986).

    Google Scholar 

  14. V. S. Chadwick, S. F. Phillips, and A. F. Hofmann. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 73:247–251 (1977).

    Google Scholar 

  15. M. L. G. Gardner. Gastrointestinal absorption of intact proteins. Annu. Rev. Nutr. 8:329–350 (1988).

    Google Scholar 

  16. A. L. Warshaw, C. A. Bellini, and W. A. Walker. The intestinal mucosal barrier to intact antigenic protein. Difference between colon and small intestine. Am. J. Surg. 133:55–58 (1977).

    Google Scholar 

  17. J. Hastewell, S. Lynch, I. Williamson, R. Fox, and M. Mackay. Absorption of human calcitonin across the rat colon in vivo. Clin. Sci. 82:589–594 (1992).

    Google Scholar 

  18. A. N. Elias, I. Gordon, N. D. Vaziri, G. Chune, M. R. Pandian, G. Gwinup, and R. Wesley. Effective portal insulin delivery with enzyme-protected capsules in pancreatectomized pigs. Gen. Pharmac. 23:55–59 (1992).

    Google Scholar 

  19. E. Quadros, J. Cassidy, K. Gniecko, and S. LeRoy. Buccal and colonic absorption of CGS 16617, a novel ACE inhibitor. J. Control. Release 19:77–86 (1991).

    Google Scholar 

  20. G. Parsons and C. R. Paterson. Fluid and solute transport across rat colonic mucosa. Q. J. Exp. Physiol. 50:220–231 (1965).

    Google Scholar 

  21. R. J. Schilling and A. K. Mitra. Intestinal transports of insulin. Int. J. Pharm. 62:53–64 (1990).

    Google Scholar 

  22. B. Matuszewska, G. G. Liversidge, F. Ryan, J. Dent, and P. L. Smith. In vitro study of intestinal absorption and metabolism of 8-L-arginine vasopressin and its analogues. Int. J. Pharm. 46:111–120 (1988).

    Google Scholar 

  23. N. M. Landzert, K. Gniecko, and E. Quadros. Protein digestion in the gastrointestinal tract. Pharm. Res. 9:S179 (1992).

    Google Scholar 

  24. M. Laburthe, C. Rouyer-Fessard, and S. Gammeltoft. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am. J. Physiol. 254:G457–G462 (1988).

    Google Scholar 

  25. B. Termanini, R. V. Nardi, T. M. Finan, I. Parikh, and L. Y. Korman. Insulin-like growth factor I receptors in rabbit gastrointestinal tract. Gastroenterology 99:51–60 (1990).

    Google Scholar 

  26. J. A. McRoberts, R. Aranda, N. Riley, and H. Kang. Insulin regulates the paracellular permeability of cultured intestinal epithelial cell monolayers. J. Clin. Invest. 85:1127–1134 (1990).

    Google Scholar 

  27. J. A. McRoberts, N. Riley, R. Aranda, and H. Kang. Regulation of colonic epithelial cell tight junction permeability by insulin-like growth factors. 2nd International Symposium on Insulin-like Growth Factors/Somatomedins, 1991.

  28. M. Narawane and V. H. L. Lee. Growth factors as penetration enhancers for transepithelial protein transport. Pharm. Res. 9:S-242 (1992).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quadros, E., Landzert, N.M., LeRoy, S. et al. Colonic Absorption of Insulin-like Growth Factor I in Vitro . Pharm Res 11, 226–230 (1994). https://doi.org/10.1023/A:1018999106684

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018999106684

Navigation